A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...

Other pharmaceutical companies are also entering the race to develop oral GLP-1 treatments. Eli Lilly is testing an experimental drug called orforglipron which targets the same pathway as semaglutide.

Starting price of $149 offers improved accessibility compared to market prices of brand-name medications which can be 8x ...

Discover what the supplement Lemme GLP-1 Daily does and whether its ingredients are really effective for weight and blood ...

According to a recent poll, one in eight American adults report that they have used a glucagon-like peptide-1 agonist ...

An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so ...

Six individuals have received this year's Lasker Awards in the areas of basic research, clinical research, and public service ...

Kourtney, the one who married Travis Barker and sees herself as ‘not like the other Kardashians,’ has a supplements line ...

For significant weight loss, Zepbound may be the better option. If you have Type 2 diabetes and are looking for a dual ...

As a critical care doctor, I have long considered inflammation a necessary evil, the mechanism through which our bodies sound ...

Researchers examine the role of GLP-2 in regulating food intake through its effects on gastrointestinal motility and satiety ...